Literature DB >> 2651313

Identification of non-immunoglobulin A-Fc-binding forms and low-molecular-weight secreted forms of the group B streptococcal beta antigen.

L J Brady1, M D Boyle.   

Abstract

The beta antigen expressed on the surfaces of certain strains of group B streptococci has been reported to bind to the Fc region of human immunoglobulin A (IgA). In this study, we screened 100 isolates of group B streptococci for expression of both beta antigen and IgA-Fc-binding activity. We identified two isolates which expressed the beta antigen but could not bind human IgA Fc fragments and also observed variability in IgA-Fc-binding activity among other beta-antigen-expressing strains. Novel low-molecular-weight forms of beta antigen were secreted by four beta-antigen surface-negative isolates and included IgA-Fc-binding (Mrs, 55,000 and 53,000) and non-IgA-Fc-binding (Mr, 38,000) molecules. These results suggest that the IgA-Fc-binding site represents a unique domain of the beta antigen. The 55,000- and 53,000-Mr forms of secreted beta antigen were functionally and antigenically representative of the size-heterogeneous (Mr, up to 145,000) beta-antigen molecules expressed by surface-positive strains. The cell surface-localized IgA-Fc-binding molecules could bind only human serum IgA efficiently; however, once solubilized, these molecules could bind both human serum and secretory IgAs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2651313      PMCID: PMC313316          DOI: 10.1128/iai.57.5.1573-1581.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Isolation of a C (Ibc) protein from group B Streptococcus which elicits mouse protective antibody.

Authors:  M V Valtonen; D L Kasper; N J Levy
Journal:  Microb Pathog       Date:  1986-04       Impact factor: 3.738

Review 2.  Group B streptococcal infection in humans.

Authors:  H W Wilkinson
Journal:  Annu Rev Microbiol       Date:  1978       Impact factor: 15.500

3.  Group B streptococcal neonatal and infant infections.

Authors:  R A Franciosi; J D Knostman; R A Zimmerman
Journal:  J Pediatr       Date:  1973-04       Impact factor: 4.406

4.  Transmission of group B streptococci among parturient women and their neonates.

Authors:  C J Baker; F F Barrett
Journal:  J Pediatr       Date:  1973-12       Impact factor: 4.406

5.  "Protein A" from S. aureus. I. Pseudo-immune reaction with human gamma-globulin.

Authors:  A Forsgren; J Sjöquist
Journal:  J Immunol       Date:  1966-12       Impact factor: 5.422

6.  A surface component in group A, C, and G streptococci with non-immune reactivity for immunoglobulin G.

Authors:  G Kronvall
Journal:  J Immunol       Date:  1973-11       Impact factor: 5.422

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Standardization and evaluation of the CAMP reaction for the prompt, presumptive identification of Streptococcus agalactiae (Lancefield group B) in clinical material.

Authors:  C L Darling
Journal:  J Clin Microbiol       Date:  1975-02       Impact factor: 5.948

9.  Complete covalent structure of a human IgA1 immunoglobulin.

Authors:  Y S Liu; T L Low; A Infante; F W Putnam
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

10.  Type-specific antigens of group B type Ic streptococci.

Authors:  H W Wilkinson; R G Eagon
Journal:  Infect Immun       Date:  1971-11       Impact factor: 3.441

View more
  13 in total

1.  High expression of a C protein beta antigen gene among invasive strains from certain clonally related groups of type Ia and Ib group B streptococci.

Authors:  Noriyuki Nagano; Yukiko Nagano; Fumiaki Taguchi
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

2.  Colloidal gold immunolabeling of immunoglobulin-binding sites and beta antigen in group B streptococci.

Authors:  S E Coleman; L J Brady; M D Boyle
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

3.  Nonimmune binding of human immunoglobulin A to type II group B streptococci.

Authors:  B F Anthony; N F Concepcion; S M Puentes; N R Payne
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

4.  Identification of an immunoglobulin A binding motif located in the beta-antigen of the c protein complex of group B streptococci.

Authors:  P G Jerlström; S R Talay; P Valentin-Weigand; K N Timmis; G S Chhatwal
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 5.  Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens.

Authors:  Gunnar Lindahl; Margaretha Stålhammar-Carlemalm; Thomas Areschoug
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

6.  Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity.

Authors:  J L Michel; L C Madoff; D E Kling; D L Kasper; F M Ausubel
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

7.  Inactivation of DNA-binding response regulator Sak189 abrogates beta-antigen expression and affects virulence of Streptococcus agalactiae.

Authors:  Anastasia S Rozhdestvenskaya; Artem A Totolian; Alexander V Dmitriev
Journal:  PLoS One       Date:  2010-04-19       Impact factor: 3.240

8.  Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein.

Authors:  L C Madoff; J L Michel; E W Gong; A K Rodewald; D L Kasper
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

9.  Phenotypic diversity in the alpha C protein of group B streptococci.

Authors:  L C Madoff; S Hori; J L Michel; C J Baker; D L Kasper
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

10.  Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes.

Authors:  L C Madoff; L C Paoletti; J Y Tai; D L Kasper
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.